Stocks and Investing Stocks and Investing
Tue, July 13, 2021

Judah Frommer Initiated (ATAI) at Buy and Held Target at $25 on, Jul 13th, 2021


Published on 2024-10-27 17:10:46 - WOPRAI, Judah Frommer
  Print publication without navigation


Judah Frommer of Credit Suisse, Initiated "Atai Life Sciences N.V." (ATAI) at Buy and Held Target at $25 on, Jul 13th, 2021.

Judah has made no other calls on ATAI in the last 4 months.



There is 1 other peer that has a rating on ATAI. Out of the 1 peers that are also analyzing ATAI, 0 agree with Judah's Rating of Hold.



This is the rating of the analyst that currently disagrees with Judah


  • Nathan Weinstein of "Aegis Capital" Initiated at Strong Buy and Held Target at $26 on, Thursday, July 8th, 2021

Contributing Sources